Pharmstandard OJSC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmstandard OJSC with three other
pharmaceutical manufacturers in Europe:
sales of 852.62 million Euro [US$904.16 million]
of which 56%
was Companion Animals),
of the United Kingdom
(£664.95 million [US$801.15 million]
of which 100%
was Buprenorphine Based Drugs), and
based in Spain
(684.99 million Euro [US$726.39 million]
of which 69%
was Own Network (Spain)).
During the year ended December of 2015, sales at
Pharmstandard OJSC were 47.19 billion Russian Rubles (US$788.16 million).
increase of 14.5%
versus 2014, when the company's sales were 41.22 billion Russian Rubles.
Despite this increase, sales are still
below the level achieved in 2013, when Pharmstandard OJSC
reported sales of 55.91 billion Russian Rubles.
Sales of Medical Equipment and Disposables saw an increase
that was more than double the company's growth rate: sales were up
40.6% in 2015, from
1.12 billion Russian Rubles to 1.58 billion Russian Rubles.